The Impact of Long-Term Clinical Evidence on Cost-Effectiveness of Exenatide Once Weekly (Bydureon®) Versus Insulin Glargine for Patients With Type 2 Diabetes Mellitus (T2dm) From A Uk Nhs Perspective
Charokopou, M., Vioix, H., Verheggen, B.G., Bratt, T., Franks, D.Volume:
17
Language:
english
Journal:
Value in Health
DOI:
10.1016/j.jval.2014.08.689
Date:
November, 2014
File:
PDF, 64 KB
english, 2014